NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...

NEW HAVEN, Conn. (WTNH) — Even though multiple sclerosis, also known as MS, is a chronic lifelong disease, there are ways to manage and treat it. Recently, the FDA approved a new drug, Tyruko, ...

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...

Scientists have identified two previously unknown biological subtypes of multiple sclerosis (MS) using artificial ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Frontline treatment options and the benefits of early intervention of MS are illustrated. Ryan Haumschild, PharmD, MS, MBA: It’s creating those pathways too that might be unique for a patient. They ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows. The two ...

Modern disease-modifying drugs (DMTs) have revolutionized the treatment of relapsing-remitting multiple sclerosis (MS). However, their use during pregnancy has long been concerning. A study published ...

In the fall of 2002, I woke up in my Christopher Newport University dorm with blinding pain in my temples. The pain was so acute that it caused partial vision loss. I visited four doctors within a ...